This prospective cohort study in Mexico City investigated the association between pre-pregnancy BMI (pBMI) and monthly gestational weight gain (MGWG) with maternal cardiometabolic risk indicators (total cholesterol, triglycerides, glucose, and blood pressure) during pregnancy. 720 women were included. Women with pre-gestational obesity had higher lipid concentrations initially, but these increased less than in normal-weight women. By the end of pregnancy, obese women had lower lipid concentrations. However, they had higher glucose and blood pressure levels throughout pregnancy. pBMI, but not MGWG, was significantly associated with cardiometabolic risk trajectories, suggesting pBMI is a more relevant predictor of adverse outcomes during pregnancy than MGWG.
Publisher
Nutrition and Diabetes
Published On
Nov 25, 2021
Authors
Luz Isabel Omaña-Guzmán, Luis Ortiz-Hernández, Mónica Ancira-Moreno, Vanesa Morales-Hernández, Marie S. O'Neill, Felipe Vadillo-Ortega
Tags
pre-pregnancy BMI
gestational weight gain
maternal health
cardiometabolic risk
pregnancy
obesity
cholesterol
Related Publications
Explore these studies to deepen your understanding of the subject.